Oct 16, 2020
5:8
For every 8 shares held, investors received 5. The price per share adjusted from $11.16 to $17.86.
The split itself did not change the total investment value.
Ceryvyn Therapeutics Limited (OTC:CYVNY) operates in the Biotechnology industry.
Ceryvyn Therapeutics Limited company overviewCeryvyn Therapeutics Limited's most recent stock split was on October 16, 2020. It was a 5-for-8 reverse split, so shareholders received 5 shares for every 8 they held.
Ceryvyn Therapeutics Limited has split its stock once. This history records one reverse split, on October 16, 2020.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Ceryvyn Therapeutics Limited's 5-for-8 reverse split on October 16, 2020, every 8 shares became 5 shares. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Ceryvyn Therapeutics Limited has not announced a new split in our records. Its most recent split was on October 16, 2020, 6 years ago. Companies announce splits in advance, and any new OTC:CYVNY split will appear on this page.
Already premium?